About Novocure Novocure is a global oncology firm working to increase survival in a number of the most aggressive varieties of most cancers as a result of the development and commercialization of its innovative therapy, Tumor Dealing with Fields. Novocure’s commercialized goods are approved in certain nations around the world for the treatment method of Grownup patients with glioblastoma, malignant pleural mesothelioma and pleural mesothelioma.
Corporate social duty is essential to us, and sufferers continue being at the heart on the work we do on a daily basis.
Determined by the treatment method achievement in GBM, TTFields are being investigated in a variety of other sound tumours beyond the brain20. Period II clinical trials are already finished in mesothelioma, ovarian cancer, NSCLC and pancreatic adenocarcinoma. Phase III trials are underway in pancreatic adenocarcinoma and NSCLC. The FDA has designated the TTFields shipping and delivery program as being a humanitarian use device with the treatment method of pleural mesothelioma.
study all tales about us our Tale our Management company presentation advocacy ESG exterior funding our therapy our products and solutions Optune Gio® Optune Lua® our pipeline our pipeline novocuretrials.com Trader relations Trader relations household inventory facts company presentation SEC filings press releases company governance Professions news and media information and media press kit push releases impression gallery patient-forward affected person-forward Extra Details company compliance california shopper privateness see privacy detect hipaa privacy detect terms and conditions web-site map novocure vulnerability disclosure approach On This great site, movies and pictures determined as Optune users, caregivers or healthcare industry experts depict actual people, caregivers and healthcare pros. Affected individual visuals mirror the health standing with the individuals at time Each individual Image or video was taken.
TTFields’ special mechanism of action underscores critical details linked to its powerful administration and clinical advantage. In contrast to chemotherapeutic agents, TTFields are only active when the arrays are affixed into the scalp as well as alternating electric fields are generated between the transducer arrays. Like a loco-regional and non-invasive focused therapy, TTFields has the benefit of preventing systemic adverse occasions associated with chemotherapy and targeted systemic therapies. The main remedy-linked adverse occasion knowledgeable by some patients with TTFields is skin irritation beneath the arrays, that's predictable and easily manageable in nearly all of circumstances.
about us our Tale our leadership company presentation advocacy ESG exterior funding our therapy our solutions Optune Gio® Optune Lua® our pipeline our pipeline novocuretrials.com investor relations Trader relations dwelling stock information corporate presentation SEC filings push releases corporate governance Professions news and media news and media push kit push releases picture gallery individual-ahead affected person-ahead Further Information and facts corporate compliance california purchaser privateness recognize privacy detect hipaa privacy notice stipulations web page map novocure vulnerability disclosure method On This great site, films and images determined as Optune people, caregivers or healthcare experts depict precise sufferers, caregivers and healthcare experts. Affected person visuals reflect the well being standing from the clients at the time Every Photograph or online video was taken.
Particular immune checkpoint inhibitors have been authorised for the 1st-line procedure of NSCLC as well as the normal of care During this environment appears to get evolving promptly. The conventional of care for next-line treatment is usually evolving and may include things like platinum-centered chemotherapy for clients who obtained immune checkpoint inhibitors as their initial-line program, docetaxel, immune checkpoint inhibitors or pemetrexed. It truly is estimated that around forty six,000 clients receive second-line remedy for metastatic NSCLC every year inside the U.S.
Our founders created a special approach to fight cancer. We channel that founding spirit into our science, business enterprise and client interactions to deliver innovative and demonstrated answers built to advance cancer care. aim
Along with our patients, we strive to extend survival in a few of the most aggressive sorts of most cancers by acquiring and commercializing our modern therapy. Find out more about our Tale, from our founding in Haifa, Israel in 2000 to getting grown into a global oncology firm nowadays.
Testimonials of the greatest nationwide and Worldwide goods / Revisões dos melhores produtos nacionais e internacionais
learn more Learn more about our business and our nervocure mission via tales about clients, our colleagues, our collaborators and our society. Back again about us our story our leadership company presentation advocacy ESG external funding our therapy our merchandise Optune Gio® Optune Lua® our pipeline our pipeline novocuretrials.
See our press kit, examine tales about our enterprise and attain out for those who’d like an job interview or maybe more specifics of Novocure.
Tumor Dealing with Fields have revealed a dependable anti-mitotic outcome inside our preclinical and medical exploration spanning over 20 years.
about us our therapy our merchandise our pipeline investor relations Occupations news and media patient-ahead Get hold of us